This inventor holds 1 USPTO granted patent. Top assignee: Restore Vision Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sharron Acosta: Innovator in Ophthalmic Formulations
Introduction
Sharron Acosta is a notable inventor based in Shavano Park, TX (US). She has made significant contributions to the field of ophthalmology through her innovative work in pharmaceutical formulations. Her dedication to improving vision care has led to the development of a unique patent that addresses presbyopia.
Latest Patents
Sharron Acosta holds a patent for "Ophthalmic formulations for the treatment of presbyopia." This patent discloses a pharmaceutical formulation that comprises a nanoparticle composition, which provides controlled delivery of one or a combination of therapeutic agents. The formulation includes a plurality of coated nanoparticles, where the coated nanoparticle consists of a core particle containing a solid pharmaceutical agent or its salt. Furthermore, the patent outlines methods for treating various ophthalmic conditions or diseases by administering a therapeutically effective amount of the disclosed pharmaceutical formulation.
Career Highlights
Sharron Acosta is associated with Restore Vision Inc., where she continues to advance her research and development efforts. Her work is pivotal in creating effective treatments for vision-related issues, particularly presbyopia, which affects a significant portion of the aging population.
Collaborations
Some of her notable coworkers include Arthur A Medina, Jr. and Joseph Terrence Kavanagh. Their collaboration enhances the innovative environment at Restore Vision Inc., fostering advancements in ophthalmic treatments.
Conclusion
Sharron Acosta's contributions to ophthalmic formulations exemplify her commitment to improving vision care. Her innovative patent and collaboration with esteemed colleagues position her as a key figure in the field of ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile